查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1543999

登革熱檢測的全球市場

Dengue Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 158 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球登革熱檢測市場將達到 7.408 億美元

全球登革熱檢測市場預計 2023 年為 5.31 億美元，預計到 2030 年將達到 7.408 億美元，2023-2030 年分析期間複合年成長率為 4.9%。醫院最終用途是本報告分析的細分市場之一，預計複合年成長率為 5.8%，到分析期結束時將達到 3.678 億美元。在分析期間，診斷中心最終用途細分市場的複合年成長率預計為 4.5%。

美國市場預估為1.433億美元，中國預期複合年成長率為8.3%

預計 2023 年美國登革熱檢測市場規模將達 1.433 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達1.613億美元，2023-2030年分析期間複合年成長率為8.3%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 2.4% 和 4.0%。在歐洲，德國的複合年成長率預計為 3.2%。

全球登革熱檢測市場—主要趨勢與促進因素總結

什麼是登革熱？

登革熱是一種蚊媒病毒性疾病，主要流行於世界各地的熱帶和亞熱帶氣候地區，對公共衛生構成嚴重挑戰。此疾病由四種登革熱病毒血清型中的一種引起，症狀可從輕度發燒到嚴重的流感樣症狀，嚴重時可發展為登革出血熱或登革熱休克症候群，有時甚至導致死亡。準確檢測登革熱不僅對於正確的臨床管理至關重要，而且對於限制疾病的傳播也至關重要。早期診斷可以幫助更有效地控制症狀並減少疾病進展為更嚴重的形式。此外，在流行地區區分登革熱與其他發燒疾病對於有針對性的公共衛生應對和有效的資源分配至關重要。

登革熱測試是如何進行的以及涉及哪些技術？

登革熱測試涉及多種調查方法，具體取決於疾病的階段。在早期階段，可以使用RT-PCR檢測檢測病毒RNA，該檢測具有高度特異性，並且可以識別病毒的血清型。隨著疾病的進展，重點轉移到使用 ELISA（酵素結合免疫吸附檢測法）檢測來檢測抗體，該檢測可以區分 IgM 和 IgG 抗體。 IgM 抗體通常在症狀出現後約 5 天即可檢測到，表示最近感染，而 IgG 抗體出現較晚，可能表示由於過去感染或不同血清型的繼發性感染而導致增強。快速診斷測試（RDT）也已被開發出來，儘管它們通常不如實驗室測試那麼具體，但其易用性和快速性使其在資源有限的環境中具有重要的測試價值。

登革熱檢測面臨哪些挑戰？

儘管診斷技術取得了進步，登革熱檢測仍面臨重大挑戰。主要問題之一是與茲卡和屈公病等其他黃病毒的交叉反應，這可能導致誤診。這在這些病毒共存的地區尤其成問題。另一個挑戰是敏感性和特異性的可變性，尤其是快速診斷測試，這可能導致假陰性和假陽性。這種不準確可能會對患者護理和疾病監測產生嚴重影響。此外，病毒和抗體的檢測時間相對較短，因此需要及時進行檢測，但在偏遠或服務不足的地區並不總是可行。這些挑戰凸顯了持續研究和開發的必要性，以提高登革熱檢測方法的準確性、可及性和可靠性。

推動登革熱檢測市場成長的因素有哪些？

登革熱檢測市場的成長受到多種因素的推動，其中包括全球登革熱流行率的上升。由於全球旅行者的增加以及有利於蚊子繁殖的氣候條件，登革熱正在蔓延到傳統的地理邊界之外，增加了對診斷測試的需求。旨在減少登革熱傳播的公共衛生努力也刺激了這項需求，特別是在實施了更嚴格監測和控制措施的流行國家。生物技術的進步使得開發更快、更準確和更具成本效益的測試成為了主要的成長動力。此外，人們對登革熱的經濟和健康影響的認知不斷提高，導致公共和私營部門在預防保健和診斷方面的投資增加。最後，COVID-19大流行提高了全球對感染疾病的認知，讓我們意識到及時、準確檢測的關鍵作用，並進一步加速了登革熱診斷領域的投資和創新。這些技術、經濟和社會促進因素反映出人們越來越關注改善公共衛生基礎設施，以更有效地管理登革熱和其他媒介傳播疾病，並推動市場的穩定成長。

受訪企業範例（12家知名企業）

  • Abbott Laboratories, Inc.
  • Abnova Corporation
  • Certest Biotec SL
  • Euroimmun AG
  • InBios International
  • NovaTec Immundiagnostica GmbH
  • OriGene Technologies, Inc.
  • Quest Diagnostics, Inc.
  • Roche Molecular Systems Inc.
  • Thermo Fisher Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP11491

Global Dengue Testing Market to Reach US$740.8 Million by 2030

The global market for Dengue Testing estimated at US$531.0 Million in the year 2023, is expected to reach US$740.8 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$367.8 Million by the end of the analysis period. Growth in the Diagnostic Centers End-Use segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$143.3 Million While China is Forecast to Grow at 8.3% CAGR

The Dengue Testing market in the U.S. is estimated at US$143.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$161.3 Million by the year 2030 trailing a CAGR of 8.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Dengue Testing Market - Key Trends and Drivers Summarized

What Is Dengue and Why Is Accurate Testing Crucial?

Dengue fever is a mosquito-borne viral disease prevalent primarily in tropical and subtropical climates worldwide, posing significant public health challenges. Caused by one of the four dengue virus serotypes, it presents a wide range of symptoms from mild fever to severe flu-like conditions, and in critical cases, it can progress to dengue hemorrhagic fever or dengue shock syndrome, which can be fatal. Accurate testing for dengue is crucial not only for appropriate clinical management but also for controlling the spread of the disease. Early diagnosis helps in managing the symptoms more effectively and can reduce the progression to more severe forms. Moreover, distinguishing dengue from other febrile illnesses in endemic regions is essential for targeted public health responses and efficient resource allocation.

How Are Dengue Tests Conducted and What Technologies Are Involved?

Dengue testing involves several methodologies that depend on the stage of the illness. In the early stages, viral RNA can be detected using RT-PCR tests, which are highly specific and can identify the virus serotype. As the disease progresses, the focus shifts to detecting antibodies using ELISA (enzyme-linked immunosorbent assay) tests that can differentiate between IgM and IgG antibodies. IgM antibodies are typically detectable from about five days after the onset of symptoms and indicate a recent infection, while IgG antibodies appear later and can indicate a past infection or enhancement due to secondary infection with a different serotype. Rapid diagnostic tests (RDTs) have also been developed, which are invaluable in resource-limited settings for their ease of use and quick turnaround times, although they generally offer less specificity than laboratory-based tests.

What Are the Challenges in Dengue Testing?

Despite advances in diagnostic technologies, dengue testing faces significant challenges. One major issue is the cross-reactivity with other flaviviruses such as Zika and chikungunya, which can lead to misdiagnosis. This is particularly problematic in regions where these viruses co-circulate. Another challenge is the variation in test sensitivity and specificity, especially among rapid diagnostic tests, which can lead to false negatives or false positives. Such inaccuracies can have severe implications for patient care and disease surveillance. Additionally, the window for detecting the virus or antibodies is relatively short, which necessitates timely testing that may not always be feasible in remote or underserved areas. These challenges underscore the need for ongoing research and development to enhance the accuracy, accessibility, and reliability of dengue testing methods.

What Drives the Growth in the Dengue Testing Market?

The growth in the dengue testing market is driven by several factors, beginning with the rising incidence of dengue worldwide. As global travel increases and climatic conditions favor mosquito breeding, dengue is expanding beyond traditional geographic boundaries, increasing the demand for diagnostic tests. Public health initiatives focused on controlling the spread of dengue also fuel this demand, particularly in endemic countries that are implementing more rigorous surveillance and control measures. Advances in biotechnology that have led to the development of faster, more accurate, and cost-effective tests are also significant growth drivers. Additionally, the growing awareness of the economic and health impacts of dengue has led to greater public and private sector investment in preventive care and diagnostics. Finally, the COVID-19 pandemic has heightened global attention on infectious diseases and the critical role of timely and accurate testing, further accelerating investment and innovation in the field of dengue diagnostics. These technological, economic, and social drivers ensure robust market growth, reflecting an increasing emphasis on improving public health infrastructure to manage dengue and other vector-borne diseases more effectively.

Select Competitors (Total 12 Featured) -

  • Abbott Laboratories, Inc.
  • Abnova Corporation
  • Certest Biotec S.L.
  • Euroimmun AG
  • InBios International
  • NovaTec Immundiagnostica GmbH
  • OriGene Technologies, Inc.
  • Quest Diagnostics, Inc.
  • Roche Molecular Systems Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Dengue Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Dengue Fever Drives Demand for Effective Testing Solutions
    • Growing Public Health Initiatives to Combat Dengue Bolster Testing Market
    • Technological Advancements in Diagnostic Kits Enhance Rapid and Accurate Dengue Detection
    • Expansion of Healthcare Infrastructure in Endemic Regions Spurs Market Growth
    • Increasing Travel and Migration Amplify Risks and Demand for Dengue Testing
    • Expansion of Laboratory and In-Clinic Testing Capacities in Developing Countries
    • Increasing Use of Point-of-Care Testing Devices for Dengue in Remote Areas
    • Rising Demand for Molecular Diagnostic Tests for Early Dengue Detection
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for ELISA-Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for ELISA-Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for ELISA-Based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for RT-PCR Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for RT-PCR Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for RT-PCR Based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Public Health Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Dengue IgG / IgM Rapid Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Dengue IgG / IgM Rapid Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Dengue IgG / IgM Rapid Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Dengue Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Dengue Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Dengue Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Dengue Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Dengue Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Dengue Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION